COMORBID HYPERPROLIFERATIVE PATHOLOGY OF MYOMETRIUM AND ENDOMETRIUM IN PATIENTS WITH ABNORMAL UTERINE BLEEDING

In: The Odessa Medical Journal · 2023 · pp. 37–41 · doi:10.32782/2226-2008-2023-2-6 · W4386870816
article OA: gold CC0

Abstract

Hyperplastic processes of the endo- and myometrium in women of reproductive and premenopausal age are in most cases clinical and morphological manifestations of an unfavorable premorbid background, systemic disorders of the woman's body, manifested by their frequent combination with extragenital pathology, inflammatory processes of the genitals, benign diseases of the ovaries and mammary glands, endometriosis and associated infertility. The aim of the study was to assess the prevalence of comorbid hyperproliferative pathology of the myometrium and endometrium in patients with abnormal uterine bleeding. It is shown that the frequency of combination of hyperproliferative diseases of the endometrium and uterine fibroids is 30.8% of the total hospitalization of gynecological pathology. Age over 35 years old is an important predictor of the development of comorbid hyperproliferative pathology of the uterus. The main clinical manifestation of the combination of uterine fibroids with proliferative diseases of the uterus is abnormal uterine bleeding. It is noted that taking into account the clinical features of the combined hyperproliferative pathology of myometrium and endometrium is necessary when choosing a treatment method. The article is available at the Institutional Repository of Odesa National Medical University http://journal.odmu.edu.ua/?p=7575&lang=en

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (10)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK